Adaptimmune Therapeutics plc (ADAP)
NASDAQ: ADAP · Real-Time Price · USD
0.709
-0.014 (-1.95%)
Dec 3, 2024, 12:10 PM EST - Market open
Adaptimmune Therapeutics Employees
Adaptimmune Therapeutics had 449 employees as of December 31, 2023. The number of employees decreased by 85 or -15.92% compared to the previous year.
Employees
449
Change (1Y)
-85
Growth (1Y)
-15.92%
Revenue / Employee
$389,846
Profits / Employee
-$99,145
Market Cap
181.45M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
InfuSystem Holdings | 516 |
Editas Medicine | 265 |
Enanta Pharmaceuticals | 145 |
Senseonics Holdings | 132 |
Heron Therapeutics | 126 |
KORU Medical Systems | 82 |
Zura Bio | 15 |
Inhibikase Therapeutics | 9 |
ADAP News
- 20 hours ago - First Patient Treated with Adaptimmune's TECELRA(R) (afamitresgene autoleucel) - Newsfile Corp
- 19 days ago - Adaptimmune Therapeutics plc (ADAP) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 19 days ago - Adaptimmune Reports Q3 2024 Financial and Business Updates - Newsfile Corp
- 20 days ago - Adaptimmune's Lete-cel Achieves Primary Endpoint in Pivotal Trial - Newsfile Corp
- 4 weeks ago - Adaptimmune to Participate in Scientific and Medical Conferences this November and December - Newsfile Corp
- 4 weeks ago - Adaptimmune to Report Q3 2024 Financial and Business Updates on Wednesday, November 13, 2024 - Newsfile Corp
- 3 months ago - Adaptimmune to Participate in Two Bank Conferences this September - Newsfile Corp
- 4 months ago - Adaptimmune Therapeutics plc (ADAP) Q2 2024 Earnings Call Transcript - Seeking Alpha